These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9717775)
1. Effects of immunosuppressants on concanavalin A-induced interleukin-2 mRNA expression in mouse liver. Okamoto T; Kobayashi T Jpn J Pharmacol; 1998 Jul; 77(3):261-3. PubMed ID: 9717775 [TBL] [Abstract][Full Text] [Related]
2. Effects of concanavalin A treatment on CD8 mRNA expression in mouse liver. Okamoto T; Nakano Y; Tsuzuike N; Hara K Jpn J Pharmacol; 1998 Sep; 78(1):97-9. PubMed ID: 9804070 [TBL] [Abstract][Full Text] [Related]
3. Expression of cytokine mRNA in extrahepatic organs in a mouse concanavalin A-hepatitis model. Okamoto T; Nakano Y; Asakura W; Kobayashi T; Tsuzuike N; Hara K Jpn J Pharmacol; 1998 Jul; 77(3):219-25. PubMed ID: 9717769 [TBL] [Abstract][Full Text] [Related]
4. [Gene expressions of LTC4 synthase homologs in Con A-induced mouse hepatitis and regulative effect of cyclosporine A]. Qi LY; Ma KF; Lai FF Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 May; 36(3):241-6. PubMed ID: 17571306 [TBL] [Abstract][Full Text] [Related]
5. Effects of concanavalin A on cytokine mRNA expression in mouse liver. Okamoto T; Kobayashi T Jpn J Pharmacol; 1997 Oct; 75(2):199-201. PubMed ID: 9414037 [TBL] [Abstract][Full Text] [Related]
6. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469 [TBL] [Abstract][Full Text] [Related]
7. Effect of gadolinium chloride treatment on concanavalin A-induced cytokine mRNA expression in mouse liver. Okamoto T; Maeda O; Tsuzuike N; Hara K Jpn J Pharmacol; 1998 Sep; 78(1):101-3. PubMed ID: 9804071 [TBL] [Abstract][Full Text] [Related]
8. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. Tiegs G; Hentschel J; Wendel A J Clin Invest; 1992 Jul; 90(1):196-203. PubMed ID: 1634608 [TBL] [Abstract][Full Text] [Related]
9. The protective effect of cyclosporine A on anti-Fas antibody-induced hepatitis in mice. Okamoto T; Hitomi Y; Hara A Jpn J Pharmacol; 1999 Apr; 79(4):485-8. PubMed ID: 10361889 [TBL] [Abstract][Full Text] [Related]
10. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653 [TBL] [Abstract][Full Text] [Related]
11. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice. Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651 [TBL] [Abstract][Full Text] [Related]
12. Ethyl pyruvate pretreatment attenuates concanavalin a-induced autoimmune hepatitis in mice. Shen M; Lu J; Cheng P; Lin C; Dai W; Wang F; Wang C; Zhang Y; Chen K; Xu L; Zhou Y; Guo C PLoS One; 2014; 9(2):e87977. PubMed ID: 24498418 [TBL] [Abstract][Full Text] [Related]
13. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α. Jakubowski A; Sternak M; Jablonski K; Ciszek-Lenda M; Marcinkiewicz J; Chlopicki S Int Immunopharmacol; 2016 Feb; 31():98-104. PubMed ID: 26709075 [TBL] [Abstract][Full Text] [Related]
14. Possible changes in expression of chemotaxin LECT2 mRNA in mouse liver after concanavalin A-induced hepatic injury. Segawa Y; Itokazu Y; Inoue N; Saito T; Suzuki K Biol Pharm Bull; 2001 Apr; 24(4):425-8. PubMed ID: 11305608 [TBL] [Abstract][Full Text] [Related]
15. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-κB-mediated CX3CL1/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation. Ren J; Meng S; Yan B; Yu J; Liu J Mol Med Rep; 2016 Apr; 13(4):3627-38. PubMed ID: 26955849 [TBL] [Abstract][Full Text] [Related]
16. Prevention of concanavalin A-induced mice hepatitis by molsidomine. Okamoto T; Masuda Y; Kawasaki T Int J Mol Med; 2001 Mar; 7(3):307-9. PubMed ID: 11179512 [TBL] [Abstract][Full Text] [Related]
17. Pregnenolone 16α-carbonitrile ameliorates concanavalin A-induced liver injury in mice independent of the nuclear receptor PXR activation. Kodama S; Shimura T; Kuribayashi H; Abe T; Yoshinari K Toxicol Lett; 2017 Apr; 271():58-65. PubMed ID: 28237809 [TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of the T cell activation pathway by dexamethasone and cyclosporine. Furue M; Kawakami Y; Kawakami T; Katz SI Transplantation; 1990 Mar; 49(3):560-4. PubMed ID: 2156362 [TBL] [Abstract][Full Text] [Related]
19. Emodin protects against concanavalin A-induced hepatitis in mice through inhibiting activation of the p38 MAPK-NF-κB signaling pathway. Xue J; Chen F; Wang J; Wu S; Zheng M; Zhu H; Liu Y; He J; Chen Z Cell Physiol Biochem; 2015; 35(4):1557-70. PubMed ID: 25792514 [TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone on the expression of interleukin-2 in a mouse T cell line. Sorg BA; Magnuson NS; Reeves R Int J Biochem; 1989; 21(9):961-70. PubMed ID: 2687057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]